Navigation Links
Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
Date:10/29/2007

GAITHERSBURG, Md., Oct. 29 /PRNewswire/ -- Sequoia Pharmaceuticals, Inc., which discovers and develops novel antiviral therapeutics as well as pharmacokinetic enhancers, announced today the appointment of Steven D. Skolsky as its President and Chief Executive Officer. He will also serve as a member of the Board of Directors.

"Sequoia is pleased to have recruited such an outstanding, talented leader as Steven Skolsky," said Chris Mirabelli, Chairman of the Board of Sequoia Pharmaceuticals. "Steve has an impressive record of success within the pharmaceutical industry. The combination of his leadership and management experience, as well as his business acumen, makes Steve uniquely qualified to lead us through the exciting times ahead."

"Sequoia possesses an extraordinary scientific pedigree, and a very attractive research portfolio. I am honored to have the opportunity to lead Sequoia, and to build on its outstanding technological progress as we move towards commercialization", said Mr. Skolsky.

Mr. Skolsky brings over twenty-five years of U.S. and international experience in the pharmaceutical and biotechnology arena. He most recently served as chief executive officer of Trimeris, a biotechnology company specializing in HIV therapeutics. Previously Mr. Skolsky had a distinguished career at GlaxoSmithKline where he served as GSK's Senior Vice President of Global Commercial Strategy responsible for world-wide clinical development and product strategy. He also served as managing director of GSK's operations in Australia and New Zealand and previously was Vice President of Sales and Marketing of the HIV/Oncology Division at Glaxo Wellcome. He is a graduate of the University of North Carolina at Chapel Hill.

About Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments, primarily for viral diseases including HIV/AIDS and HCV-induced hepatitis. In addition, Sequoia has an active R&D program in pharmacokinetic enhancers.


'/>"/>
SOURCE Sequoia Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas ...
(Date:6/23/2016)... -- Guerbet announced today that it has been named a ... One of 12 suppliers to receive the ... of Premier members through exceptional local customer service and ... lower costs. "We ... customer service from Premier," says Massimo Carrara , ...
(Date:6/23/2016)... , June 23, 2016 ... "Surgical Procedure Volumes: Global Analysis (United States, China, ... Canada)" report to their offering. ... essential tool for healthcare business planners, provides surgical procedure ... at surgery trends with an in-depth analysis of growth ...
Breaking Medicine Technology: